Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $6.18 Million - $7.46 Million
37,300 Added 293.7%
50,000 $8.46 Million
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $1.92 Million - $2.54 Million
12,700 New
12,700 $2.51 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $11.1 Million - $14.2 Million
-99,400 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$92.66 - $144.94 $9.21 Million - $14.4 Million
99,400 New
99,400 $11.7 Million
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $430,125 - $493,025
-3,700 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$112.57 - $128.43 $416,509 - $475,191
3,700 New
3,700 $461,000
Q1 2019

May 08, 2019

SELL
$81.56 - $100.67 $187,588 - $231,541
-2,300 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$79.28 - $95.27 $182,344 - $219,121
2,300 New
2,300 $197,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.